{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:36:08Z","timestamp":1788438968502,"version":"build-2803163510"},"reference-count":26,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Anti-dsDNA is an important biomarker for the diagnosis, prognosis, and monitoring of systemic lupus erythematosus (SLE). Although several assays for anti-dsDNA antibody detection are routinely used, standardization remains limited, and differences have been reported. This study aimed to compare five methods for anti-dsDNA antibody detection and to estimate their association with complement consumption. Methods: A total of 149 samples submitted for routine laboratory testing were collected and tested on five platforms: Crithidia luciliae indirect immunofluorescence test (CLIFT), addressable laser bead immunoassay (ALBIA), a high-avidity (HA) enzyme-linked immunosorbent assay (ELISA), chemiluminescent immunoassay (CIA), and a novel particle-based multi-analyte technology (PMAT). Complements C3 and C4 were available for a subset of the total samples. Results: Correlation between anti-dsDNA assays ranged from 0.94 (CIA and PMAT) to 0.65 (ALBIA and CLIFT). The AUC from the ROC analysis using CLIFT as a reference was 0.95 for PMAT, 0.94 for CIA, 0.93 for ELISA, and 0.86 for ALBIA. The highest sensitivity relative to CLIFT at a fixed specificity of 94.4% was 84.7% for CIA and ELISA, 76.3% for PMAT, and 42.4% for ALBIA. Correlation between anti-dsDNA and C3 ranged from \u22120.81 for ELISA to \u22120.51 for ALBIA. Conclusions: Different anti-dsDNA detection methods showed varying diagnostic performance and correlation and varying agreement with CLIFT and complement consumption. ELISA, CIA, and PMAT showed high correlation to each other and to CLIFT and were in strong concordance with low C3 levels. In contrast, ALBIA revealed lower clinical performance and correlation with CLIFT and complement consumption.<\/jats:p>","DOI":"10.3390\/diagnostics15192430","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:19:45Z","timestamp":1758701985000},"page":"2430","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of Five Assays for the Detection of Anti-dsDNA Antibodies and Their Correlation with Complement Consumption"],"prefix":"10.3390","volume":"15","author":[{"given":"Vincent","family":"Ricchiuti","sequence":"first","affiliation":[{"name":"Labcorp North Central Regional Reference Laboratory, Dublin, OH 43016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Obney","sequence":"additional","affiliation":[{"name":"Labcorp North Central Regional Reference Laboratory, Dublin, OH 43016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4526-885X","authenticated-orcid":false,"given":"Brooke","family":"Holloway","sequence":"additional","affiliation":[{"name":"Research and Development, Werfen Autoimmunity, San Diego, CA 92131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1971-0411","authenticated-orcid":false,"given":"Mary Ann","family":"Aure","sequence":"additional","affiliation":[{"name":"Research and Development, Werfen Autoimmunity, San Diego, CA 92131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marti","family":"Shapiro","sequence":"additional","affiliation":[{"name":"Research and Development, Werfen Autoimmunity, San Diego, CA 92131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsea","family":"Bentow","sequence":"additional","affiliation":[{"name":"Research and Development, Werfen Autoimmunity, San Diego, CA 92131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mahler","sequence":"additional","affiliation":[{"name":"Research and Development, Werfen Autoimmunity, San Diego, CA 92131, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Villalta, D., Bizzaro, N., Bassi, N., Zen, M., Gatto, M., Ghirardello, A., Iaccarino, L., Punzi, L., Doria, A., and Rieux-Laucat, F. (2013). Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0071458"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s12016-007-8046-x","article-title":"IgM antibodies against dsDNA in SLE","volume":"34","author":"Witte","year":"2008","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/09612033221074184","article-title":"IgA anti-dsDNA antibodies: A neglected serological parameter in systemic lupus erythematosus","volume":"31","author":"Lee","year":"2022","journal-title":"Lupus"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jim.2018.05.014","article-title":"The clinical utility of anti-double-stranded DNA antibodies and the challenges of their determination","volume":"459","author":"Mummert","year":"2018","journal-title":"J. Immunol. Methods"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"902821","DOI":"10.1155\/2015\/902821","article-title":"Clinical comparison of QUANTA Flash dsDNA chemiluminescent immunoassay with four current assays for the detection of anti-dsDNA autoantibodies","volume":"2015","author":"Infantino","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e000984","DOI":"10.1136\/lupus-2023-000984","article-title":"Longitudinal study of patients with discrepant results in CLIFT and a solid-phase dsDNA antibody assay: Does a gold standard dsDNA assay exist?","volume":"10","author":"Aguilera","year":"2023","journal-title":"Lupus Sci. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1191\/0961203303lu277oa","article-title":"Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring","volume":"12","author":"Villalta","year":"2003","journal-title":"Lupus"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1177\/0961203310369681","article-title":"Autoantibodies to double-stranded DNA\u2014Intermethod comparison between four commercial immunoassays and a research biosensor-based device","volume":"19","author":"Fiegel","year":"2010","journal-title":"Lupus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/08923973.2015.1077461","article-title":"Detection of autoantibodies using chemiluminescence technologies","volume":"38","author":"Mahler","year":"2016","journal-title":"Immunopharmacol. Immunotoxicol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1093\/rheumatology\/kez092","article-title":"Autoantibodies to Mi-2 alpha and Mi-2 beta in patients with idiopathic inflammatory myopathy","volume":"58","author":"Richards","year":"2019","journal-title":"Rheumatology"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ayano, M., and Horiuchi, T. (2023). Complement as a Biomarker for Systemic Lupus Erythematosus. Biomolecules, 13.","DOI":"10.3390\/biom13020367"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1177\/0961203319877243","article-title":"Clinical evaluation of total and high-avidity anti-dsDNA antibody assays for the diagnosis of systemic lupus erythematosus","volume":"28","author":"Yuan","year":"2019","journal-title":"Lupus"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1191\/0961203306lu2308oa","article-title":"Anti-dsDNA antibody subtypes and anti-C1q antibodies: Toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis","volume":"15","author":"Jaekell","year":"2006","journal-title":"Lupus"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"100139","DOI":"10.1016\/j.jtauto.2021.100139","article-title":"Anti-dsDNA antibodies in the classification criteria of systemic lupus erythematosus","volume":"5","author":"Infantino","year":"2022","journal-title":"J. Transl. Autoimmun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s13075-022-02980-x","article-title":"Multiparametric autoantibody analysis: A new paradigm for the diagnosis of connective tissue diseases","volume":"24","author":"Bizzaro","year":"2022","journal-title":"Arthritis Res. Ther."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1109\/TVCG.2014.2346248","article-title":"UpSet: Visualization of Intersecting Sets","volume":"20","author":"Lex","year":"2014","journal-title":"IEEE Trans. Vis. Comput. Graph."},{"key":"ref_18","unstructured":"(2025, June 27). Practice Surveys. Available online: https:\/\/www.cap.org\/advocacy\/latest-news-and-practice-data\/practice-surveys."},{"key":"ref_19","unstructured":"UK NEQAS for Antibodies to Nuclear and Related Antigens (2025, June 27). UK NEQAS Immunology, Immunochemistry & Allergy. Available online: https:\/\/www.immqas.org.uk\/."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e13220","DOI":"10.1111\/sji.13220","article-title":"Comparison of current methods for anti-dsDNA antibody detection and reshaping diagnostic strategies","volume":"96","author":"Infantino","year":"2022","journal-title":"Scand. J. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e001012","DOI":"10.1136\/lupus-2023-001012","article-title":"Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE","volume":"10","author":"Zaminski","year":"2023","journal-title":"Lupus Sci. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1177\/09612033231179888","article-title":"A comparison of the chemiluminescence immunoassay and Crithidia luciliae immunofluorescence test in detecting anti-dsDNA antibodies and assessing the activity of systemic lupus erythematosus","volume":"32","author":"He","year":"2023","journal-title":"Lupus"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10067-017-3771-x","article-title":"The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patients","volume":"37","author":"Zhao","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"109155","DOI":"10.1016\/j.intimp.2022.109155","article-title":"Potential biomarkers for diagnosis and assessment of disease activity in systemic lupus erythematosus","volume":"111","author":"Zhang","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/iid3.401","article-title":"Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity","volume":"9","author":"Shang","year":"2021","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s10067-013-2330-3","article-title":"Immunoserological parameters in SLE: High-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity","volume":"32","author":"Andrejevic","year":"2013","journal-title":"Clin. Rheumatol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/19\/2430\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:48:34Z","timestamp":1760035714000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/19\/2430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":26,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["diagnostics15192430"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15192430","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]}}}